Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- AKLIDELISTED
- Price
- -
- Stock movement up
- +- (0.00%)
- Company name
- Akili Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Health Information Services
- Market cap
- 34.01M
- Ent value
- -12.17M
- Price/Sales
- 17.46
- Price/Book
- 0.68
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -61.08%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2024-12-16
DIVIDENDS
AKLI does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 17.46 |
| Price to Book | 0.68 |
| EV to Sales | -6.25 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 78.73M |
| EPS (TTM) | -0.62 |
| FCF per share (TTM) | -0.63 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.95M |
| Gross profit (TTM) | 1.09M |
| Operating income (TTM) | -56.23M |
| Net income (TTM) | -48.55M |
| EPS (TTM) | -0.62 |
| EPS (1y forward) | -0.46 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 56.11% |
| Operating margin (TTM) | -2886.60% |
| Profit margin (TTM) | -2492.04% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 63.34M |
| Net receivables | 144.00K |
| Total current assets | 65.00M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 2.28M |
| Total assets | 67.36M |
| Accounts payable | 1.10M |
| Short/Current long term debt | 13.59M |
| Total current liabilities | 11.21M |
| Total liabilities | 17.16M |
| Shareholder's equity | 50.21M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -48.77M |
| Capital expenditures (TTM) | 370.00K |
| Free cash flow (TTM) | -49.13M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -96.69% |
| Return on Assets | -72.06% |
| Return on Invested Capital | -77.96% |
| Cash Return on Invested Capital | -78.90% |
STOCK INFORMATION
Stock chart
No data
Stock price data
| Open | 0.43 |
| Daily high | 0.43 |
| Daily low | 0.43 |
| Daily Volume | 0K |
| 1y analyst estimate | 0.65 |
| Beta | 1.73 |
| EPS (TTM) | -0.62 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AKLI | S&P500 | |
| Current price drop from All-time high | -96.93% | - |
| Highest price drop | -98.48% | -56.47% |
| Date of highest drop | 17 Apr 2024 | 9 Mar 2009 |
| Avg drop from high | -91.12% | -10.84% |
| Avg time to new high | 237 days | 12 days |
| Max time to new high | 469 days | 1805 days |
COMPANY DETAILS
Marketcap
34.01M
Marketcap category
Small-cap
Description
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts. As of July 1, 2024, Akili, Inc. operates as a subsidiary of Virtual Therapeutics Corp.
Employees
68
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner